FOYA winners announced
Six pharmaceutical manufacturing facilities in Europe and the US win award categories
Pfizer Health won the Facility of the Year Award for Operational Excellence at its Project Pegasus – Bio 7 manufacturing facility in Strängnäs, Sweden. This microbial drug substance production plant manufactures two legacy Pfizer hormone treatments, Genotropin and Somavert. Pfizer scientists developed a manufacturing process with virtually identical unit operations that could be used for both products.
Project Pegasus won this category for Pfizer’s ability to bring a new facility online with added capacity without increasing staff numbers or extending shift patterns. This was achieved by incorporating a high degree of flexibility into the facility design. The project team also minimised manual interactions in the process.
Control system recipes were developed that enhanced the efficiency of this biotech operation. Targeted output of the facility was previously 2 batches per week, but as a result of their focus on Operational Excellence, the facility currently has the capacity to produce 3.5 batches per week.
F. Hoffman – La Roche took the Process Innovation category award for its “MyDose” clinical supply facility in Kaiseraugst, Switzerland.
MedImmune won for Project Execution at its Frederick Manufacturing Center (FMC) expansion facility in Frederick, Maryland, US, while the Facility Integration category award went to Merck and Company for its Global Clinical Supplies Manufacturing, Packaging and Warehouse expansion project in Summit, New Jersey, US.
Novartis Vaccines and Diagnostics took the Equipment Innovation category award for its “MARS Project” facility in Marburg, Germany.
The sixth winner was Pfizer Manufacturing Deutschland, which won the Sustainability category for its SPRING & E-MAP (Strategic Plant Restructuring & Energy Master Plan) project in Freiburg, Germany.
Shire HGT received an Honourable Mention for its Project Atlas, Building 400 facility in Lexington, Massachusetts, US.
Now in its seventh year, the Facility of the Year Awards, sponsored by ISPE, Interphex and Pharmaceutical Processing magazine in the US, recognise state-of-the-art pharmaceutical manufacturing projects that incorporate new and innovative technologies to enhance the delivery of a quality project, as well as reduce the cost of producing medicines.
The Overall Facility of the Year award will be presented during ISPE’s 2011 Annual Meeting, which takes place from 6–9 November in Grapevine, Texas, US.
You may also like
Trending Articles
You may also like
Manufacturing
Sharp boosts autoinjector and pen assembly line capability with $20m investment in Pennsylvania facility
The money will boost its autoinjector and pen assembly, labelling and packaging lines across various therapeutic areas at its facility in Macungie, meeting the rising demand for injectables